How to Give Carbimazole
Start carbimazole at 15-30 mg once daily (equivalent to 10-20 mg methimazole), then reduce to a maintenance dose of 5-15 mg daily (equivalent to 5-10 mg methimazole) once euthyroidism is achieved, typically within 4-12 weeks. 1
Dosing Equivalence and Administration
Carbimazole is a prodrug that rapidly converts to methimazole in the serum, with 10 mg carbimazole metabolizing to approximately 6 mg methimazole 1. Both medications work identically and can be given as a single daily dose due to their long intrathyroidal half-life 1.
Adult Dosing Regimen
Initial Therapy
- Start with 15-30 mg carbimazole once daily (higher doses for more severe hyperthyroidism) 1
- Single daily dosing is as effective as divided doses and improves compliance 2, 3
- Patients with baseline T4 >260 nmol/L may require the higher end of dosing (30-40 mg equivalent) 4
Titration Strategy
- Monitor thyroid function every 4 weeks initially 1
- Once thyroid hormones normalize (typically 4-12 weeks), reduce dose by 50% or more to maintain euthyroidism 1
- Maintenance dose: 5-15 mg carbimazole daily (equivalent to 5-10 mg methimazole) 1
Important Caveat on "Block and Replace"
Avoid "block and replace" therapy (continuing high-dose antithyroid drug plus levothyroxine), as this approach results in higher rates of adverse effects without additional benefit 1.
Pediatric Dosing
For children, use methimazole/carbimazole as first-line therapy 1:
Age-Based Dosing
- Infants: 1.25 mg/day (methimazole equivalent)
- 1-5 years: 2.5-5.0 mg/day
- 5-10 years: 5-10 mg/day
- 10-18 years: 10-20 mg/day
Weight-Based Alternative
- 0.2-0.5 mg/kg/day methimazole (range 0.1-1.0 mg/kg/day) 1
- For severe hyperthyroidism, use doses 50-100% higher initially
- Once normalized, reduce by 50% or more for maintenance 1
Pre-Treatment Monitoring (Essential)
Before starting carbimazole, obtain baseline labs 1:
- Complete blood count with differential (to detect baseline neutropenia)
- Liver function tests including bilirubin and transaminases (to detect baseline hepatic dysfunction)
Critical Safety Warnings
Patient Education (Mandatory)
Instruct patients to STOP carbimazole immediately and contact physician if they develop 1:
- Fever or pharyngitis (agranulocytosis warning)
- Jaundice, dark urine, or pale stools (hepatotoxicity)
- Pruritic rash
- Arthralgias, abdominal pain, nausea, or fatigue
Monitoring During Treatment
- Routine monitoring of CBC and liver function during treatment is not recommended as adverse effects occur rapidly and unpredictably 1
- Clinical vigilance and patient education are more important than routine lab monitoring
Special Populations
Pregnancy
- First trimester: Propylthiouracil is preferred over carbimazole/methimazole due to risk of embryopathy 1
- After first trimester: Can switch to carbimazole/methimazole
Lactation
- Carbimazole ≤10 mg/day is generally considered compatible with breastfeeding 5
- Some allow breastfeeding 4-6 hours after doses of 15-20 mg/day 5
Clinical Pearls
- Patients with small goiters and markedly elevated TSI may be "dose-sensitive" and respond rapidly to low doses (as low as 0.7-3.2 mg daily maintenance) 6
- Food increases absorption by ~40%, so consistent timing with meals improves predictability 7
- Once-daily dosing at bedtime is practical and effective 2
- Most common cause of treatment failure is nonadherence, not drug inefficacy 1